Request for Covid-19 Impact Assessment of this Report
The United States Daunorubicin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Daunorubicin market, reaching US$ million by the year 2028. As for the Europe Daunorubicin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Daunorubicin players cover Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, and Gilead Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Daunorubicin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Intravenous
Drip
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Acute Granulocyte
Acute Lymphocyte Leukemia
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Daunorubicin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Daunorubicin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Daunorubicin by Country/Region, 2017, 2022 & 2028
2.2 Daunorubicin Segment by Type
2.2.1 Intravenous
2.2.2 Drip
2.3 Daunorubicin Sales by Type
2.3.1 Global Daunorubicin Sales Market Share by Type (2017-2022)
2.3.2 Global Daunorubicin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Daunorubicin Sale Price by Type (2017-2022)
2.4 Daunorubicin Segment by Application
2.4.1 Acute Granulocyte
2.4.2 Acute Lymphocyte Leukemia
2.5 Daunorubicin Sales by Application
2.5.1 Global Daunorubicin Sale Market Share by Application (2017-2022)
2.5.2 Global Daunorubicin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Daunorubicin Sale Price by Application (2017-2022)
3 Global Daunorubicin by Company
3.1 Global Daunorubicin Breakdown Data by Company
3.1.1 Global Daunorubicin Annual Sales by Company (2020-2022)
3.1.2 Global Daunorubicin Sales Market Share by Company (2020-2022)
3.2 Global Daunorubicin Annual Revenue by Company (2020-2022)
3.2.1 Global Daunorubicin Revenue by Company (2020-2022)
3.2.2 Global Daunorubicin Revenue Market Share by Company (2020-2022)
3.3 Global Daunorubicin Sale Price by Company
3.4 Key Manufacturers Daunorubicin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Daunorubicin Product Location Distribution
3.4.2 Players Daunorubicin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Daunorubicin by Geographic Region
4.1 World Historic Daunorubicin Market Size by Geographic Region (2017-2022)
4.1.1 Global Daunorubicin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Daunorubicin Annual Revenue by Geographic Region
4.2 World Historic Daunorubicin Market Size by Country/Region (2017-2022)
4.2.1 Global Daunorubicin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Daunorubicin Annual Revenue by Country/Region
4.3 Americas Daunorubicin Sales Growth
4.4 APAC Daunorubicin Sales Growth
4.5 Europe Daunorubicin Sales Growth
4.6 Middle East & Africa Daunorubicin Sales Growth
5 Americas
5.1 Americas Daunorubicin Sales by Country
5.1.1 Americas Daunorubicin Sales by Country (2017-2022)
5.1.2 Americas Daunorubicin Revenue by Country (2017-2022)
5.2 Americas Daunorubicin Sales by Type
5.3 Americas Daunorubicin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Daunorubicin Sales by Region
6.1.1 APAC Daunorubicin Sales by Region (2017-2022)
6.1.2 APAC Daunorubicin Revenue by Region (2017-2022)
6.2 APAC Daunorubicin Sales by Type
6.3 APAC Daunorubicin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Daunorubicin by Country
7.1.1 Europe Daunorubicin Sales by Country (2017-2022)
7.1.2 Europe Daunorubicin Revenue by Country (2017-2022)
7.2 Europe Daunorubicin Sales by Type
7.3 Europe Daunorubicin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Daunorubicin by Country
8.1.1 Middle East & Africa Daunorubicin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Daunorubicin Revenue by Country (2017-2022)
8.2 Middle East & Africa Daunorubicin Sales by Type
8.3 Middle East & Africa Daunorubicin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Daunorubicin
10.3 Manufacturing Process Analysis of Daunorubicin
10.4 Industry Chain Structure of Daunorubicin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Daunorubicin Distributors
11.3 Daunorubicin Customer
12 World Forecast Review for Daunorubicin by Geographic Region
12.1 Global Daunorubicin Market Size Forecast by Region
12.1.1 Global Daunorubicin Forecast by Region (2023-2028)
12.1.2 Global Daunorubicin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Daunorubicin Forecast by Type
12.7 Global Daunorubicin Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Daunorubicin Product Offered
13.1.3 Sanofi Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Halison Pharmaceuiticals
13.2.1 Halison Pharmaceuiticals Company Information
13.2.2 Halison Pharmaceuiticals Daunorubicin Product Offered
13.2.3 Halison Pharmaceuiticals Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Halison Pharmaceuiticals Main Business Overview
13.2.5 Halison Pharmaceuiticals Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Daunorubicin Product Offered
13.3.3 Hikma Pharmaceuticals Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Gilead Sciences
13.4.1 Gilead Sciences Company Information
13.4.2 Gilead Sciences Daunorubicin Product Offered
13.4.3 Gilead Sciences Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Gilead Sciences Main Business Overview
13.4.5 Gilead Sciences Latest Developments
13.5 Bedford Pharmaceuticals
13.5.1 Bedford Pharmaceuticals Company Information
13.5.2 Bedford Pharmaceuticals Daunorubicin Product Offered
13.5.3 Bedford Pharmaceuticals Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bedford Pharmaceuticals Main Business Overview
13.5.5 Bedford Pharmaceuticals Latest Developments
13.6 United Biotech
13.6.1 United Biotech Company Information
13.6.2 United Biotech Daunorubicin Product Offered
13.6.3 United Biotech Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 United Biotech Main Business Overview
13.6.5 United Biotech Latest Developments
13.7 Mercian Corporation
13.7.1 Mercian Corporation Company Information
13.7.2 Mercian Corporation Daunorubicin Product Offered
13.7.3 Mercian Corporation Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Mercian Corporation Main Business Overview
13.7.5 Mercian Corporation Latest Developments
13.8 Pharmacia
13.8.1 Pharmacia Company Information
13.8.2 Pharmacia Daunorubicin Product Offered
13.8.3 Pharmacia Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Pharmacia Main Business Overview
13.8.5 Pharmacia Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Daunorubicin Product Offered
13.9.3 Cipla Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 TEVA
13.10.1 TEVA Company Information
13.10.2 TEVA Daunorubicin Product Offered
13.10.3 TEVA Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 TEVA Main Business Overview
13.10.5 TEVA Latest Developments
13.11 Medior Healthcare
13.11.1 Medior Healthcare Company Information
13.11.2 Medior Healthcare Daunorubicin Product Offered
13.11.3 Medior Healthcare Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Medior Healthcare Main Business Overview
13.11.5 Medior Healthcare Latest Developments
13.12 West-Ward
13.12.1 West-Ward Company Information
13.12.2 West-Ward Daunorubicin Product Offered
13.12.3 West-Ward Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 West-Ward Main Business Overview
13.12.5 West-Ward Latest Developments
13.13 Shandong Xinshidai Pharmaceutical
13.13.1 Shandong Xinshidai Pharmaceutical Company Information
13.13.2 Shandong Xinshidai Pharmaceutical Daunorubicin Product Offered
13.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shandong Xinshidai Pharmaceutical Main Business Overview
13.13.5 Shandong Xinshidai Pharmaceutical Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Daunorubicin Product Offered
13.14.3 HISUN Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
13.15 Shenzhen Wanle Pharmaceutical
13.15.1 Shenzhen Wanle Pharmaceutical Company Information
13.15.2 Shenzhen Wanle Pharmaceutical Daunorubicin Product Offered
13.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shenzhen Wanle Pharmaceutical Main Business Overview
13.15.5 Shenzhen Wanle Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Daunorubicin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Daunorubicin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Drip
Table 5. Global Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 6. Global Daunorubicin Sales Market Share by Type (2017-2022)
Table 7. Global Daunorubicin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Daunorubicin Revenue Market Share by Type (2017-2022)
Table 9. Global Daunorubicin Sale Price by Type (2017-2022) & (US$/Litre)
Table 10. Global Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 11. Global Daunorubicin Sales Market Share by Application (2017-2022)
Table 12. Global Daunorubicin Revenue by Application (2017-2022)
Table 13. Global Daunorubicin Revenue Market Share by Application (2017-2022)
Table 14. Global Daunorubicin Sale Price by Application (2017-2022) & (US$/Litre)
Table 15. Global Daunorubicin Sales by Company (2020-2022) & (Litre)
Table 16. Global Daunorubicin Sales Market Share by Company (2020-2022)
Table 17. Global Daunorubicin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Daunorubicin Revenue Market Share by Company (2020-2022)
Table 19. Global Daunorubicin Sale Price by Company (2020-2022) & (US$/Litre)
Table 20. Key Manufacturers Daunorubicin Producing Area Distribution and Sales Area
Table 21. Players Daunorubicin Products Offered
Table 22. Daunorubicin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Daunorubicin Sales by Geographic Region (2017-2022) & (Litre)
Table 26. Global Daunorubicin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Daunorubicin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Daunorubicin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Daunorubicin Sales by Country/Region (2017-2022) & (Litre)
Table 30. Global Daunorubicin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Daunorubicin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Daunorubicin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Daunorubicin Sales by Country (2017-2022) & (Litre)
Table 34. Americas Daunorubicin Sales Market Share by Country (2017-2022)
Table 35. Americas Daunorubicin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Daunorubicin Revenue Market Share by Country (2017-2022)
Table 37. Americas Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 38. Americas Daunorubicin Sales Market Share by Type (2017-2022)
Table 39. Americas Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 40. Americas Daunorubicin Sales Market Share by Application (2017-2022)
Table 41. APAC Daunorubicin Sales by Region (2017-2022) & (Litre)
Table 42. APAC Daunorubicin Sales Market Share by Region (2017-2022)
Table 43. APAC Daunorubicin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Daunorubicin Revenue Market Share by Region (2017-2022)
Table 45. APAC Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 46. APAC Daunorubicin Sales Market Share by Type (2017-2022)
Table 47. APAC Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 48. APAC Daunorubicin Sales Market Share by Application (2017-2022)
Table 49. Europe Daunorubicin Sales by Country (2017-2022) & (Litre)
Table 50. Europe Daunorubicin Sales Market Share by Country (2017-2022)
Table 51. Europe Daunorubicin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Daunorubicin Revenue Market Share by Country (2017-2022)
Table 53. Europe Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 54. Europe Daunorubicin Sales Market Share by Type (2017-2022)
Table 55. Europe Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 56. Europe Daunorubicin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Daunorubicin Sales by Country (2017-2022) & (Litre)
Table 58. Middle East & Africa Daunorubicin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Daunorubicin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Daunorubicin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 62. Middle East & Africa Daunorubicin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 64. Middle East & Africa Daunorubicin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Daunorubicin
Table 66. Key Market Challenges & Risks of Daunorubicin
Table 67. Key Industry Trends of Daunorubicin
Table 68. Daunorubicin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Daunorubicin Distributors List
Table 71. Daunorubicin Customer List
Table 72. Global Daunorubicin Sales Forecast by Region (2023-2028) & (Litre)
Table 73. Global Daunorubicin Sales Market Forecast by Region
Table 74. Global Daunorubicin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Daunorubicin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Daunorubicin Sales Forecast by Country (2023-2028) & (Litre)
Table 77. Americas Daunorubicin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Daunorubicin Sales Forecast by Region (2023-2028) & (Litre)
Table 79. APAC Daunorubicin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Daunorubicin Sales Forecast by Country (2023-2028) & (Litre)
Table 81. Europe Daunorubicin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Daunorubicin Sales Forecast by Country (2023-2028) & (Litre)
Table 83. Middle East & Africa Daunorubicin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Daunorubicin Sales Forecast by Type (2023-2028) & (Litre)
Table 85. Global Daunorubicin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Daunorubicin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Daunorubicin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Daunorubicin Sales Forecast by Application (2023-2028) & (Litre)
Table 89. Global Daunorubicin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Daunorubicin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Daunorubicin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Daunorubicin Product Offered
Table 94. Sanofi Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Halison Pharmaceuiticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 98. Halison Pharmaceuiticals Daunorubicin Product Offered
Table 99. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 100. Halison Pharmaceuiticals Main Business
Table 101. Halison Pharmaceuiticals Latest Developments
Table 102. Hikma Pharmaceuticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 103. Hikma Pharmaceuticals Daunorubicin Product Offered
Table 104. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 105. Hikma Pharmaceuticals Main Business
Table 106. Hikma Pharmaceuticals Latest Developments
Table 107. Gilead Sciences Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 108. Gilead Sciences Daunorubicin Product Offered
Table 109. Gilead Sciences Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 110. Gilead Sciences Main Business
Table 111. Gilead Sciences Latest Developments
Table 112. Bedford Pharmaceuticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 113. Bedford Pharmaceuticals Daunorubicin Product Offered
Table 114. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 115. Bedford Pharmaceuticals Main Business
Table 116. Bedford Pharmaceuticals Latest Developments
Table 117. United Biotech Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 118. United Biotech Daunorubicin Product Offered
Table 119. United Biotech Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 120. United Biotech Main Business
Table 121. United Biotech Latest Developments
Table 122. Mercian Corporation Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 123. Mercian Corporation Daunorubicin Product Offered
Table 124. Mercian Corporation Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 125. Mercian Corporation Main Business
Table 126. Mercian Corporation Latest Developments
Table 127. Pharmacia Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 128. Pharmacia Daunorubicin Product Offered
Table 129. Pharmacia Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 130. Pharmacia Main Business
Table 131. Pharmacia Latest Developments
Table 132. Cipla Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 133. Cipla Daunorubicin Product Offered
Table 134. Cipla Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 135. Cipla Main Business
Table 136. Cipla Latest Developments
Table 137. TEVA Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 138. TEVA Daunorubicin Product Offered
Table 139. TEVA Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 140. TEVA Main Business
Table 141. TEVA Latest Developments
Table 142. Medior Healthcare Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 143. Medior Healthcare Daunorubicin Product Offered
Table 144. Medior Healthcare Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 145. Medior Healthcare Main Business
Table 146. Medior Healthcare Latest Developments
Table 147. West-Ward Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 148. West-Ward Daunorubicin Product Offered
Table 149. West-Ward Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 150. West-Ward Main Business
Table 151. West-Ward Latest Developments
Table 152. Shandong Xinshidai Pharmaceutical Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 153. Shandong Xinshidai Pharmaceutical Daunorubicin Product Offered
Table 154. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 155. Shandong Xinshidai Pharmaceutical Main Business
Table 156. Shandong Xinshidai Pharmaceutical Latest Developments
Table 157. HISUN Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 158. HISUN Daunorubicin Product Offered
Table 159. HISUN Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 160. HISUN Main Business
Table 161. HISUN Latest Developments
Table 162. Shenzhen Wanle Pharmaceutical Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 163. Shenzhen Wanle Pharmaceutical Daunorubicin Product Offered
Table 164. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2020-2022)
Table 165. Shenzhen Wanle Pharmaceutical Main Business
Table 166. Shenzhen Wanle Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Daunorubicin
Figure 2. Daunorubicin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Daunorubicin Sales Growth Rate 2017-2028 (Litre)
Figure 7. Global Daunorubicin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Daunorubicin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intravenous
Figure 10. Product Picture of Drip
Figure 11. Global Daunorubicin Sales Market Share by Type in 2021
Figure 12. Global Daunorubicin Revenue Market Share by Type (2017-2022)
Figure 13. Daunorubicin Consumed in Acute Granulocyte
Figure 14. Global Daunorubicin Market: Acute Granulocyte (2017-2022) & (Litre)
Figure 15. Daunorubicin Consumed in Acute Lymphocyte Leukemia
Figure 16. Global Daunorubicin Market: Acute Lymphocyte Leukemia (2017-2022) & (Litre)
Figure 17. Global Daunorubicin Sales Market Share by Application (2017-2022)
Figure 18. Global Daunorubicin Revenue Market Share by Application in 2021
Figure 19. Daunorubicin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Daunorubicin Revenue Market Share by Company in 2021
Figure 21. Global Daunorubicin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Daunorubicin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Daunorubicin Sales Market Share by Region (2017-2022)
Figure 24. Global Daunorubicin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Daunorubicin Sales 2017-2022 (Litre)
Figure 26. Americas Daunorubicin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Daunorubicin Sales 2017-2022 (Litre)
Figure 28. APAC Daunorubicin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Daunorubicin Sales 2017-2022 (Litre)
Figure 30. Europe Daunorubicin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Daunorubicin Sales 2017-2022 (Litre)
Figure 32. Middle East & Africa Daunorubicin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Daunorubicin Sales Market Share by Country in 2021
Figure 34. Americas Daunorubicin Revenue Market Share by Country in 2021
Figure 35. United States Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Daunorubicin Sales Market Share by Region in 2021
Figure 40. APAC Daunorubicin Revenue Market Share by Regions in 2021
Figure 41. China Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Daunorubicin Sales Market Share by Country in 2021
Figure 48. Europe Daunorubicin Revenue Market Share by Country in 2021
Figure 49. Germany Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Daunorubicin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Daunorubicin Revenue Market Share by Country in 2021
Figure 56. Egypt Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Daunorubicin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Daunorubicin in 2021
Figure 62. Manufacturing Process Analysis of Daunorubicin
Figure 63. Industry Chain Structure of Daunorubicin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...